Spots Global Cancer Trial Database for Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma (HCC)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma (HCC)
Official Title: PhaseⅡ, Open Label, Clinical Trial to Investigate Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma
Study ID: NCT01308645
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine efficacy of SB injection in Hepatocellular Carcinoma (HCC).
Detailed Description: All eligible patients will receive SB injection therapy for 6 cycles (14\~21 days for each cycle). Efficacy wll be evaluated every 3 cycles.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Inha University Hospital, Incheon, Jung-gu, Korea, Republic of
Contact Details
Name: Lee Jin woo, Prof.
Affiliation: Inha University Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
